| Cristin Prater, | |
|
1031 Quintard Ave Ste 1a, Anniston, AL 36201-5714 | |
| (256) 231-2552 | |
| (256) 231-2550 |
| Full Name | Cristin Prater |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 1031 Quintard Ave Ste 1a, Anniston, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144766700 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 1-123807 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Affinity Cardiovascular Specialists Llc | 1658680434 | 42 |
| Salame Heart And Vascular Clinic Llc | 3274683834 | 3 |
News Archive
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
Children who lose one or both parents to HIV/AIDS are unlikely to remain in school and finish their education, Robert Greener, senior economic adviser at the United Nations Development Programme, said at the World Bank's Annual Bank Conference on Development Economics in South Africa recently, the Inter Press Service reports.
Allena Pharmaceuticals, Inc., and Althea Technologies today announced a licensing agreement under which Allena has obtained the exclusive worldwide rights to Althea's broad hyperoxaluria portfolio including product patents, regulatory information and development data related to oxalate degrading enzymes.
Allison Knigge was in elementary school when she started to experience migraines. They continued to get progressively worse as time went on, especially after the birth of her son.
› Verified 8 days ago
| Entity Name | Salame Heart And Vascular Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437390184 PECOS PAC ID: 3274683834 Enrollment ID: O20090603000139 |
News Archive
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
Children who lose one or both parents to HIV/AIDS are unlikely to remain in school and finish their education, Robert Greener, senior economic adviser at the United Nations Development Programme, said at the World Bank's Annual Bank Conference on Development Economics in South Africa recently, the Inter Press Service reports.
Allena Pharmaceuticals, Inc., and Althea Technologies today announced a licensing agreement under which Allena has obtained the exclusive worldwide rights to Althea's broad hyperoxaluria portfolio including product patents, regulatory information and development data related to oxalate degrading enzymes.
Allison Knigge was in elementary school when she started to experience migraines. They continued to get progressively worse as time went on, especially after the birth of her son.
› Verified 8 days ago
| Entity Name | Affinity Cardiovascular Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215305925 PECOS PAC ID: 1658680434 Enrollment ID: O20151016002299 |
News Archive
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
Children who lose one or both parents to HIV/AIDS are unlikely to remain in school and finish their education, Robert Greener, senior economic adviser at the United Nations Development Programme, said at the World Bank's Annual Bank Conference on Development Economics in South Africa recently, the Inter Press Service reports.
Allena Pharmaceuticals, Inc., and Althea Technologies today announced a licensing agreement under which Allena has obtained the exclusive worldwide rights to Althea's broad hyperoxaluria portfolio including product patents, regulatory information and development data related to oxalate degrading enzymes.
Allison Knigge was in elementary school when she started to experience migraines. They continued to get progressively worse as time went on, especially after the birth of her son.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cristin Prater, 1031 Quintard Ave Ste 1a, Anniston, AL 36201-5714 Ph: (256) 231-2552 | Cristin Prater, 1031 Quintard Ave Ste 1a, Anniston, AL 36201-5714 Ph: (256) 231-2552 |
News Archive
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
Children who lose one or both parents to HIV/AIDS are unlikely to remain in school and finish their education, Robert Greener, senior economic adviser at the United Nations Development Programme, said at the World Bank's Annual Bank Conference on Development Economics in South Africa recently, the Inter Press Service reports.
Allena Pharmaceuticals, Inc., and Althea Technologies today announced a licensing agreement under which Allena has obtained the exclusive worldwide rights to Althea's broad hyperoxaluria portfolio including product patents, regulatory information and development data related to oxalate degrading enzymes.
Allison Knigge was in elementary school when she started to experience migraines. They continued to get progressively worse as time went on, especially after the birth of her son.
› Verified 8 days ago
Amanda Marie Pearson, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 516 Quintard Ave, Anniston, AL 36201 Phone: 256-741-9799 Fax: 256-741-9795 | |
Ashley Marie Roberts, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5211 | |
Mary Miller, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 731 Leighton Ave, Anniston, AL 36207 Phone: 256-741-6464 | |
Cori Clark Broadhead, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 516 Quintard Ave, Anniston, AL 36201 Phone: 256-741-9799 Fax: 256-741-9795 | |
Holly Flanagan Mays, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3312 Henry Rd, Anniston, AL 36207 Phone: 256-241-2671 Fax: 256-241-2676 | |
Jessica Benedicta Coby, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5896 | |
Dr. Dhara Sandip Patel, DNP, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 731 Leighton Ave, Anniston, AL 36207 Phone: 256-741-6464 |